Our Services
Location and contact details
6th Floor, Tower 2
+632 8888 8999 local 3614

 View Location Map

Service Hours
Monday to Friday, 8:00 AM - 5:00 PM

The Cellular Therapeutics Center (CTC) provides viable alternative or adjunct cutting-edge therapy for chronic, autoimmune, and degenerative diseases such as cancer, multiple sclerosis, ischemic cardiomyopathy, psoriasis, and osteoarthritis. The Center is accredited by the Philippines’ Department of Health (DOH) as “a facility that may engage in human stem cell or cellular therapy” in accordance with Administrative Order No. 2013-012. It adheres to global standards in cellular therapeutics practice, training and research, and staffed by experienced scientists dedicated to excellence in healthcare.
The Center’s own Laboratory is at par with the United States Food and Drug Administration (US-FDA) sterility standard (ISO class 5 clean room), ensuring cell purity (at least 90 to 95%) and cell viability of the product.

Cellular Therapies:
  • Autologous Chondrocyte Implantation for Cartillage Repair
  • Dendritic Cell Therapy
    • Cancer
  • Hematopoietic Stem Cell Transplantation
    • Leukemia
    • Multiple Sclerosis
    • Others
  • Mesenchymal Stem Cell Transplantation
    • Age-Related Macular Degeneration
    • Clinical Frailty
    • Ishemic Cardiomyopathy
    • Osteoarthritis
    • Psoriasis
    • Others
  • Platelet-Rich Plasma (PRP) Therapy
Cell & Tissue Banking Services:
Acquisition and banking of human biopsies for future use or applications

Other Diagnostic Services
  • Enzyme-linked Immunosorbent Assay (ELISA)-Based Diagnostics
    • Interferon-γ (IFN-γ) for Dendritic Cell Therapy Monitoring
  • Flow Cytometry Diagnostics
    • CD34+Enumeration
    • Mesenchymal Stem Cell Immunophenotyping
    • Panel 1: CD4 Helper T-cell Immunodeficiency
    • Panel 2: CD4/CD8 Cytotoxic T-cell Immunodeficiency
    • Panel 3: CD4/CD8/CD19 B-Lymphocyte Immunodeficiency
    • Panel 4: CD16+56 Natural Killer (NK) Cell Immunodeficiency
    • Panel 5: CD19/CD20 B-Lymphocyte Immunodeficiency
    • Panel 6: CD4/CD8/CD16+56/CD19/CD20 T/B-Lymphocyte and NK Immunodeficiency
    • Reactive Oxygen Species (ROS) Activity
  • Fluorescence in situ Hybridization-based Diagnostics
    • BCR-ABL for Chronic Myelogenous Leukemia (CML)
    • HER-2/neu for Breast Cancer

Other Services:
  • Chemoresponse Assay
This test is used to generally assess the response and sensitivity of a patient's tumor cell to different chemotherapeutic drugs and combinations.
  • Cryopreservation and Thawing
  • Drugs and Specimen Storage (-20°C Freezer or -80°C Ultralow Freezer)
  • Phlebotomy and Sample Processing